A

Asterion Therapeutics (Private limited company)

BE 0715.602.553 Active ●Schaarbeekstraat(MEL) 20D, 9120 Beveren-Kruibeke-Zwijndrecht

Asterion Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0715.602.553. It was founded on 07-12-2018. Its registered office is in Beveren-Kruibeke-Zwijndrecht. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € -214 025 and a loss of € 95 406. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 0 of its last 4 financial years.

Information last updated on 15-10-2026.

Company information

Status
Active
Enterprise number
BE 0715.602.553
VAT registered
Yes
Founded
07-12-2018
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
Late for 2022, 2023, 2024, 2025
Peppol e-invoicing
Registered
Registered office
Schaarbeekstraat(MEL) 20D, 9120 Beveren-Kruibeke-Zwijndrecht
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21209 Fabrication d'autres produits pharmaceutiques
10890 Fabrication d’autres produits alimentaires nca
20420 Fabrication de parfums et de produits pour la toilette
47279 Autres commerces de détail alimentaires nca
47741 Commerce de détail d'articles médicaux et orthopédiques, à l'exception de lunettes de correction, de lentilles et de lunettes de soleil
47750 Commerce de détail de produits cosmétiques et d'articles de toilette

Key figures of Asterion Therapeutics

20252021
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -95 406€ -25 842
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -214 025€ -85 170
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 58 464€ 36 181
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -15 448€ -17 865
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
--

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
AJINOMOTO OMNICHEM 9230 Wetteren
I.D.A.S.I. 9140 Temse
-HEEL BELGIUM 9031 Gent
DELAVAL 9031 Gent
Conforma 9070 Destelbergen
Laboratoria Bota 9800 Deinze
Buckman Laboratories 9000 Gent
Etablissements Horticoles de Wanze 9140 Temse
Looking for more information about Asterion Therapeutics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Asterion Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Asterion Therapeutics as active.

What is the VAT number of Asterion Therapeutics? The VAT number of Asterion Therapeutics is BE 0715.602.553.

When was Asterion Therapeutics founded? Asterion Therapeutics was founded on 07-12-2018.

What is the address of Asterion Therapeutics? The current registered office of Asterion Therapeutics is Schaarbeekstraat(MEL) 20D, 9120 Beveren-Kruibeke-Zwijndrecht.

When did Asterion Therapeutics last file annual accounts? The latest annual accounts of Asterion Therapeutics were filed on 01-10-2026.

Does Asterion Therapeutics file its annual accounts on time? Asterion Therapeutics filed its annual accounts within the legal deadline for 0 of its last 4 financial years. Late: 2022, 2023, 2024, 2025.

Is Asterion Therapeutics financially healthy? Addrly gives Asterion Therapeutics a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Asterion Therapeutics profitable? The annual accounts of Asterion Therapeutics for 2025 show a loss of € 95 406.

What is the equity of Asterion Therapeutics? The equity of Asterion Therapeutics was € -214 025 at the close of the 2025 financial year.

Who are the directors of Asterion Therapeutics? The annual accounts of Asterion Therapeutics record 1 mandate. The name, role and dates are visible with a free account.

Can Asterion Therapeutics receive Peppol e-invoices? Yes. Asterion Therapeutics is registered on the Peppol network and can receive structured electronic invoices.

What does Asterion Therapeutics do? The main activity of Asterion Therapeutics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data